Australian biotech market today 22.05.09
Friday, 22 May, 2009
As of 3.30pm, Healthcare index is down 1% on the back of a general 1.3% drop experienced by the All Ordinaries sparked by global economic concerns.
CSL dropped 50c to $30.90 and ResMed (ASX:RMD) is also down fractionally, along with the rest of the market.
Cochlear (ASX:COH) bucked the trend by rising $1.01 to $53.01, as did Ramsay Health Care (ASX:RHC), which gained 1.1%.
Ansell (ASX:ANN) shed 39 cents to $8.21 after Barclays Group issued a notice of ceasing to be a substantial holder from 18 May.
AusBiotech partners with Tenmile
Designed to support Australia's homegrown life sciences innovation, AusBiotech has announced...
Australian CDC issues update in wake of Ebola outbreak
After the WHO determined the outbreak of Ebola in the DRC and Uganda to be a public health...
Australia announces $7.2m diphtheria outbreak response package
To respond to the biggest diphtheria outbreak on record, support has been announced for the NT...
